Jefferies says big pharma firms to get bigger; lists Sun Pharma and Syngene as top picks, downgrades Biocon, Cipla
Biocon hits 52-week low as USFDA issues complete response letter for its Insulin application
From Paytm to Biocon: These 12 Nifty 100 stocks are the biggest wealth destroyers in 2022